CFAs: Ending the Smoking Epidemic by Advancing Global Research for Innovative Smoking Cessation

Proposals responsive to this RFP should fill scientific gaps in the evidence base related to tobacco use and smoking cessation through novel and non-duplicative research. This may include traditional cessation approaches, as well as the potential role of reduced risk nicotine products.

Topics

• Suggested topics include, but are not limited to, public health research areas covering various topics, such as:
  • Tobacco use, smoking cessation, and/or the potential impact of reduced risk products on cessation and public health outcomes
  • Rigorous evaluation research to test the effectiveness of education and dissemination interventions
  • Health systems change or health care delivery research specific to smoking cessation outcomes
  • Sociodemographic research about disparities in smoking prevalence and cessation outcomes in LMICs or HICs
  • Health economics research related to evidence-based tobacco control programs and/or reduced-risk nicotine products
  • Implementation research to expand and improve evidence-based interventions or to develop novel demonstration projects.

Funding Information

• Awards for this announcement may not exceed USD 2,500,000 per project.
• Duration: The scope of the proposed project should determine the project duration. The maximum duration shall not exceed 24 months.

Geographical Focus

• GA’s goal is to fund investigator-initiated projects that generate new knowledge specific to populations disproportionately burdened by the smoking epidemic in both HICs and LMICs. A geographic priority is countries with historically high smoking rates and disease burden from traditional tobacco use, with a focus on LMICs and populations that are most at risk for premature morbidity and mortality.

Eligibility Criteria

• Eligible institutions include academic, think-tank, and health-related research and science centers, and other collaborating centers and institutions with experience in related subject areas such as public health, behavioral health, psychology, epidemiology, economics, disease prevention, and health communications. Previous experience in research related to smoking cessation, tobacco control, marginalized populations, or harm reduction-informed approaches to public health is desirable, but not required. Proposals should be submitted by entities registered in their country of origin with an ability to accept grants from not-for-profit foundations incorporated in the United States.

Evaluation Criteria 

• The following criteria will be used to evaluate submissions:
  • Significance of the research question and potential to advance knowledge or public health practice
  • Methodological approach and description of hypotheses, study design, sample size, statistical analyses, human subjects’ protections (if applicable), and rationale for study population or country
  • Necessary and sufficient preliminary evidence used to establish scientific plausibility
  • Feasibility of the research plan, list of study deliverables, and timelines
  • The expertise and prior experience of the Principal Investigator and named staff, including demonstrated experience on similar projects
  • The research environment including description of adequate physical, financial, and intellectual resources to meet the aims of the proposed project
  • Capacity to conduct research aligned with Open Science principles
  • The communication and dissemination plan for results, as appropriate to the scope of the research
  • Budget relative to significance/impact of the proposed research and scientific contribution
  • Key organizational documents provided to GA as part of the due diligence process.

For more information, visit Global Action to End Smoking.